Adult Patients With Moderately to Severely Active Ulcerative Colitis Clinical Trials in Guangzhou, Guangdong

A Phase 2 Study to Evaluate the Efficacy, Safety and Pharmacokinetics of SHR-1139 in Patients With Moderate-to-severe Active Ulcerative Colitis